Azithromycin dry suspension

The active ingredient of this product is azithromycin

This product is white to light yellow granules or powders.

Azithromycin is a macrolide antibacterial drug indicated for the treatment of mild to moderate infections caused by susceptible strains of designated microorganisms in the following specific conditions. Acute exacerbation of bacterial infection of chronic bronchitis caused by Haemophilus influenzae, Moraxella catarrhalis, or Streptococcus pneumoniae. Community-acquired pneumonia caused by Chlamydia pneumoniae, Haemophilus influenzae, Mycoplasma pneumoniae, or Streptococcus pneumoniae. Acute otitis media caused by Haemophilus influenzae, Moraxella catarrhalis, or Streptococcus pneumoniae. Acute bacterial sinusitis caused by Haemophilus influenzae, Moraxella catarrhalis, or Streptococcus pneumoniae. Pharyngitis/tonsillitis caused by Streptococcus pyogenes. Uncomplicated skin and skin structure infections caused by Staphylococcus aureus, Streptococcus pyogenes, or Streptococcus agalactiae. Urethritis and cervicitis caused by Chlamydia trachomatis or Neisseria gonorrhoeae. Male genital ulcer disease (chancroid) caused by Haemophilus ducreyi. Due to the small number of women recruited in the clinical trial, the efficacy of azithromycin in the treatment of female chancroid has not been determined. The safety and effectiveness of this product in the treatment of acute otitis media, acute bacterial sinusitis and community-acquired pneumonia in children under 6 months of age have not been determined; the safety and effectiveness of this product in the treatment of pharyngitis/tonsillitis in children under 2 years of age have not been determined (see [Children's Use]).

Take the medicine orally once a day. Dissolve in water and stir well before taking. It can be taken with or without food. Azithromycin suspension is used to treat various infectious diseases. The course of treatment and usage are as follows: (See instructions for details)

Sealed, store in a dry place.

0.1 g (based on C38H72N2012)

24 months

Changchun HaiYue Pharmaceutical Limited By Share Ltd.

• Founded in:

  1992-09-12

• Address:

  No. 5555, Shuangying Road, Shuangyang Economic Development Zone, Shuangyang District, Changchun City

• Tax NO.:

  912201016059030427

• Registered Funds:

  226.1666 million yuan

• Email:

  Log in to view